Jump to main content
Jump to site search

Issue 30, 2014
Previous Article Next Article

Polymorphism control of an active pharmaceutical ingredient beneath calixarene-based Langmuir monolayers

Author affiliations

Abstract

This communication demonstrates the possibility to nucleate and grow different crystalline polymorphic forms of gabapentin (GBP) using, as nucleation templates, Langmuir monolayers of an amphiphilic calixarene at different packing densities.

Graphical abstract: Polymorphism control of an active pharmaceutical ingredient beneath calixarene-based Langmuir monolayers

Back to tab navigation

Supplementary files

Publication details

The article was received on 04 Feb 2014, accepted on 20 Feb 2014 and first published on 05 Mar 2014


Article type: Communication
DOI: 10.1039/C4CC00928B
Citation: Chem. Commun., 2014,50, 3938-3940
  •   Request permissions

    Polymorphism control of an active pharmaceutical ingredient beneath calixarene-based Langmuir monolayers

    L. G. Tulli, N. Moridi, W. Wang, K. Helttunen, M. Neuburger, D. Vaknin, W. Meier and P. Shahgaldian, Chem. Commun., 2014, 50, 3938
    DOI: 10.1039/C4CC00928B

Search articles by author

Spotlight

Advertisements